Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Christine Van Broeckhoven, PhD, DSc from the Neurodegenerative Brain Diseases group, VIB, Antwerp, Belgium gives us a summary of two sessions, both focused on a novel genetic risk factor for dementia, presented at the 2017 Alzheimer’s Association International Conference (AAIC) in London, UK.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.